Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
2.150
+0.090 (4.37%)
Nov 21, 2024, 4:00 PM EST - Market closed
Cocrystal Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 13.02 | 26.35 | 37.14 | 58.71 | 33.01 | 7.42 | Upgrade
|
Cash & Short-Term Investments | 13.02 | 26.35 | 37.14 | 58.71 | 33.01 | 7.42 | Upgrade
|
Cash Growth | -56.22% | -29.05% | -36.73% | 77.84% | 345.00% | 172.42% | Upgrade
|
Accounts Receivable | - | - | - | - | 0.56 | 0.64 | Upgrade
|
Other Receivables | 0.65 | 0.89 | 0.72 | - | - | - | Upgrade
|
Receivables | 0.65 | 0.89 | 0.72 | - | 0.56 | 0.64 | Upgrade
|
Prepaid Expenses | 0.51 | 0.49 | 0.54 | 0.57 | 0.4 | 0.17 | Upgrade
|
Restricted Cash | 0.08 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | Upgrade
|
Other Current Assets | - | 1.28 | 1.7 | - | - | - | Upgrade
|
Total Current Assets | 14.26 | 29.09 | 40.18 | 59.32 | 34.02 | 8.28 | Upgrade
|
Property, Plant & Equipment | 1.95 | 2.12 | 0.62 | 0.93 | 1.09 | 1.11 | Upgrade
|
Goodwill | - | - | - | 19.09 | 19.09 | 19.09 | Upgrade
|
Other Long-Term Assets | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
Total Assets | 16.23 | 31.26 | 40.84 | 79.39 | 54.24 | 28.53 | Upgrade
|
Accounts Payable | 1.66 | 1.22 | 0.61 | 0.58 | 0.66 | 1.51 | Upgrade
|
Accrued Expenses | - | 1.8 | 0.36 | 0.72 | 0.42 | 0.49 | Upgrade
|
Current Portion of Leases | 0.29 | 0.24 | 0.24 | 0.24 | 0.22 | 0.28 | Upgrade
|
Other Current Liabilities | - | - | - | 0.01 | 0.06 | 0.01 | Upgrade
|
Total Current Liabilities | 1.95 | 3.26 | 1.22 | 1.55 | 1.36 | 2.29 | Upgrade
|
Long-Term Leases | 1.58 | 1.61 | 0.06 | 0.3 | 0.38 | 0.54 | Upgrade
|
Total Liabilities | 3.53 | 4.88 | 1.27 | 1.84 | 1.74 | 2.82 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | 0.04 | Upgrade
|
Additional Paid-In Capital | 342.85 | 342.29 | 337.49 | 336.63 | 297.34 | 260.93 | Upgrade
|
Retained Earnings | -330.15 | -315.91 | -297.93 | -259.09 | -244.91 | -235.26 | Upgrade
|
Total Common Equity | 12.7 | 26.38 | 39.57 | 77.55 | 52.51 | 25.71 | Upgrade
|
Shareholders' Equity | 12.7 | 26.38 | 39.57 | 77.55 | 52.51 | 25.71 | Upgrade
|
Total Liabilities & Equity | 16.23 | 31.26 | 40.84 | 79.39 | 54.24 | 28.53 | Upgrade
|
Total Debt | 1.88 | 1.85 | 0.3 | 0.53 | 0.6 | 0.82 | Upgrade
|
Net Cash (Debt) | 11.15 | 24.5 | 36.85 | 58.17 | 32.41 | 6.6 | Upgrade
|
Net Cash Growth | -62.37% | -33.51% | -36.66% | 79.46% | 391.05% | 175.96% | Upgrade
|
Net Cash Per Share | 1.09 | 2.54 | 4.52 | 7.90 | 7.04 | 2.49 | Upgrade
|
Filing Date Shares Outstanding | 10.17 | 10.17 | 8.14 | 8.12 | 5.96 | 4.35 | Upgrade
|
Total Common Shares Outstanding | 10.17 | 10.17 | 8.14 | 8.12 | 5.87 | 2.93 | Upgrade
|
Working Capital | 12.31 | 25.83 | 38.96 | 57.78 | 32.66 | 6 | Upgrade
|
Book Value Per Share | 1.25 | 2.59 | 4.86 | 9.55 | 8.94 | 8.78 | Upgrade
|
Tangible Book Value | 12.7 | 26.38 | 39.57 | 58.46 | 33.41 | 6.62 | Upgrade
|
Tangible Book Value Per Share | 1.25 | 2.59 | 4.86 | 7.20 | 5.69 | 2.26 | Upgrade
|
Machinery | - | 1.91 | 1.76 | 1.69 | 1.62 | 1.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.